237 related articles for article (PubMed ID: 34224408)
1. Long-term outcomes and independent predictors of mortality in patients presenting to emergency departments with acute heart failure in Beijing: a multicenter cohort study with a 5-year follow-up.
Li Y; Sun XL; Qiu H; Qin J; Li CS; Yu XZ; Wang GX; Fu Y; Zheng YA; Zhao B; Yu DM; Wang SJ; Wang GG
Chin Med J (Engl); 2021 Jun; 134(15):1803-1811. PubMed ID: 34224408
[TBL] [Abstract][Full Text] [Related]
2. Association between anemia and outcome in patients hospitalized for acute heart failure syndromes: findings from Beijing Acute Heart Failure Registry (Beijing AHF Registry).
Ye SD; Wang SJ; Wang GG; Li L; Huang ZW; Qin J; Li CS; Yu XZ; Shen H; Yang LP; Fu Y; Zheng YA; Zhao B; Yu DM; Qin FJ; Zhou DG; Li Y; Liu FJ
Intern Emerg Med; 2021 Jan; 16(1):183-192. PubMed ID: 32356137
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic value of N-terminal B-type natriuretic peptide on all-cause mortality in heart failure patients with preserved ejection fraction].
Cao J; Jin XJ; Zhou J; Chen ZY; Xu DL; Yang XC; Dong W; Li LW; Luo J; Chen L; Fu M; Zhou JM; Ge JB
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):875-881. PubMed ID: 31744276
[No Abstract] [Full Text] [Related]
4. Clinical Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease: Insights From PARADIGM-HF.
Ehteshami-Afshar S; Mooney L; Dewan P; Desai AS; Lang NN; Lefkowitz MP; Petrie MC; Rizkala AR; Rouleau JL; Solomon SD; Swedberg K; Shi VC; Zile MR; Packer M; McMurray JJV; Jhund PS; Hawkins NM
J Am Heart Assoc; 2021 Feb; 10(4):e019238. PubMed ID: 33522249
[TBL] [Abstract][Full Text] [Related]
5. Long-term survival after hospitalization for acute heart failure--differences in prognosis of acutely decompensated chronic and new-onset acute heart failure.
Lassus JP; Siirilä-Waris K; Nieminen MS; Tolonen J; Tarvasmäki T; Peuhkurinen K; Melin J; Pulkki K; Harjola VP;
Int J Cardiol; 2013 Sep; 168(1):458-62. PubMed ID: 23073273
[TBL] [Abstract][Full Text] [Related]
6. Characteristics, Management, and Outcomes of Acute Heart Failure in the Emergency Department: A Multicenter Registry Study with 1-year Follow-up in a Chinese Cohort in Beijing.
Wang GG; Wang SJ; Qin J; Li CS; Yu XZ; Shen H; Yang LP; Fu Y; Zheng YA; Zhao B; Yu DM; Qin FJ; Zhou DG; Li Y; Liu FJ; Li W; Zhao W; Gao X; Wang Z; Jin M; Zeng H; Li Y; Wang GX; Zhou H; Sun XL; Wang PB; Woo KS
Chin Med J (Engl); 2017 Aug; 130(16):1894-1901. PubMed ID: 28776539
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of carbohydrate antigen 125 combined with N-terminal pro B-type natriuretic peptide in patients with acute heart failure.
Chen X; Wu M; Xu K; Huang M; Zhuo X
Acta Cardiol; 2021 Feb; 76(1):87-92. PubMed ID: 32519930
[TBL] [Abstract][Full Text] [Related]
8. BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial.
Pfisterer M; Buser P; Rickli H; Gutmann M; Erne P; Rickenbacher P; Vuillomenet A; Jeker U; Dubach P; Beer H; Yoon SI; Suter T; Osterhues HH; Schieber MM; Hilti P; Schindler R; Brunner-La Rocca HP;
JAMA; 2009 Jan; 301(4):383-92. PubMed ID: 19176440
[TBL] [Abstract][Full Text] [Related]
9. Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients.
Wang Y; Zhang R; Huang Y; Zhai M; Zhou Q; An T; Huang Y; Zhao X; Tian P; Zhang Y; Zhang J
Clin Chim Acta; 2019 Apr; 491():8-14. PubMed ID: 30594544
[TBL] [Abstract][Full Text] [Related]
10. Time-Dependent Changes in N-Terminal Pro-Brain Natriuretic Peptide and B-Type Natriuretic Peptide Ratio During Hospitalization for Acute Heart Failure.
Sawatani T; Shirakabe A; Okazaki H; Matsushita M; Shibata Y; Shigihara S; Nishigoori S; Sasamoto N; Kiuchi K; Kobayashi N; Shimizu W; Asai K
Int Heart J; 2023; 64(2):213-222. PubMed ID: 37005316
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic role of NT-proBNP in emergency department in the elderly with acute heart failure].
Martín Sánchez FJ; Covarrubias M; Terán C; Llorens P; Herrero P; Jacob J; Gil V; Fernández C; Miró O;
Rev Esp Geriatr Gerontol; 2013; 48(4):155-60. PubMed ID: 23528263
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of the N-terminal pro-brain natriuretic peptide and B-type natriuretic peptide ratio in the acute phase of acute heart failure.
Sawatani T; Shirakabe A; Okazaki H; Matsushita M; Shibata Y; Shigihara S; Otsuka Y; Kiuchi K; Kobayashi N; Hata N; Shimizu W; Asai K
Eur Heart J Acute Cardiovasc Care; 2021 Dec; 10(9):1016-1026. PubMed ID: 34432003
[TBL] [Abstract][Full Text] [Related]
13. [Predictive value of N-terminal B-type natriuretic peptide on outcome of elderly hospitalized non-heart failure patients].
Li YY; Liang YD; Yao SM; Zheng PP; Zeng XZ; Cui LL; Guo D; Wang H; Yang JF
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Aug; 48(8):661-668. PubMed ID: 32847322
[No Abstract] [Full Text] [Related]
14. Ischemic biomarker heart-type fatty acid binding protein (hFABP) in acute heart failure - diagnostic and prognostic insights compared to NT-proBNP and troponin I.
Hoffmann U; Espeter F; Weiß C; Ahmad-Nejad P; Lang S; Brueckmann M; Akin I; Neumaier M; Borggrefe M; Behnes M
BMC Cardiovasc Disord; 2015 Jun; 15():50. PubMed ID: 26072112
[TBL] [Abstract][Full Text] [Related]
15. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
[TBL] [Abstract][Full Text] [Related]
16. Relationship and prognostic importance of thyroid hormone and N-terminal pro-B-Type natriuretic peptide for patients after acute coronary syndromes: a longitudinal observational study.
Brozaitiene J; Mickuviene N; Podlipskyte A; Burkauskas J; Bunevicius R
BMC Cardiovasc Disord; 2016 Feb; 16():45. PubMed ID: 26892923
[TBL] [Abstract][Full Text] [Related]
17. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
[TBL] [Abstract][Full Text] [Related]
18. Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department.
Januzzi JL; Sakhuja R; O'donoghue M; Baggish AL; Anwaruddin S; Chae CU; Cameron R; Krauser DG; Tung R; Camargo CA; Lloyd-Jones DM
Arch Intern Med; 2006 Feb; 166(3):315-20. PubMed ID: 16476871
[TBL] [Abstract][Full Text] [Related]
19. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
20. Predictors of Long-Term Mortality in Patients With Acute Heart Failure.
Jin M; Wei S; Gao R; Wang K; Xu X; Yao W; Zhang H; Zhou Y; Xu D; Zhou F; Li X
Int Heart J; 2017 May; 58(3):409-415. PubMed ID: 28496020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]